Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)

Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)

Abstract Background Vestibular migraine (VM) is the most frequent cause of recurrent spontaneous attacks of vertigo causally related to migraine. The objective of the Prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG) trial was to demonstrate that metoprolol succinate is superi...

Full description

Bibliographic Details
Main Authors: Otmar Bayer, Christine Adrion, Amani Al Tawil, Ulrich Mansmann, Michael Strupp, PROVEMIG investigators
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Trials
Subjects:
Vestibular migraine
Episodic migraine
Patient-centred outcomes
Symptom diary
Pharmaceutical intervention
Pharmacological prophylaxis
Online Access:https://doi.org/10.1186/s13063-019-3903-5

Internet

https://doi.org/10.1186/s13063-019-3903-5

Similar Items